All News

As the capital markets have improved, more investors have shifted their concern from weathering the financial crisis to anticipating the inflationary effects of rising federal spending and debt.

Authors from two recent studies discuss the risks men face in undergoing biopsy as well as the steps urologists are taking to minimize these risks.

As employers (and individuals) select health insurance plans with higher deductibles that place more financial responsibility on the patient, it's more important than ever that medical practices revamp front office collection procedures and place more responsibility on the front office staff.

Within the next year or so, depending on how quickly the FDA acts, the U.S. may be getting its first therapeutic agent specifically indicated for the treatment of premature ejaculation.

Urologists share a diverse range of lessons they've learned since they started practicing.

A novel minimally invasive system for the treatment of lower urinary tract symptoms due to BPH appears to be safe and efficacious for as long as 2 years after the procedure is performed.

A nanotechnology PSA assay shows potential for identifying prostate cancer patients at increased risk of recurrence after radical prostatectomy.

A novel experimental technology for removing kidney stone fragments using magnetic energy has passed a pair of early tests.

Urodynamic results do correlate with treatment outcomes in idiopathic overactive bladder treatment, at least with onabotulinumtoxin A (Botox). Surprisingly, despite all the urodynamic studies done in OAB, this is new information.

Although inflammation in deceased donor kidneys represent an increased risk in acute transplant failures, there is no causal connection, Austrian researchers say.

Less than 1 month remains for physicians to file a claim for the $350 million settlement reached against UnitedHealth Group and its Ingenix subsidiary for its flawed out-of-network reimbursement database.

In men with localized prostate cancer, high-intensity focused ultrasound (HIFU) offers a rate of cancer-specific survival at 8 years similar to that expected with external beam radiation therapy, French researchers reported.

Every newborn child should be screened for congenital adrenal hyperplasia (CAH) and positive results should be followed by testing, according to a new clinical practice guideline from the Endocrine Society on the diagnosis and treatment of the condition.

In men with a low serum baseline PSA level, the benefits of additional screening or treatment appear to be, European researchers reported.

UCLA scientists say they have identified for the first time a cell-of-origin for human prostate cancer, a discovery that could result in better predictive and diagnostic tools and the development of more effective targeted treatments for the disease.

Short-term and long-term costs of prostate cancer care vary considerably based on which treatment strategy a man initially receives, according to a recent study.

Men exposed in the womb to the pesticide dichlorodiphenyltrichloroethane (DDT) and its related compounds are more likely to develop testicular cancer, say researchers from Child Health and Development Studies (CHDS), Berkeley, CA.

Men using commonly prescribed medications?nonsteroidal anti-inflammatory drugs, statins, and thiazide diuretics?appear to experience reduced PSA levels by clinically significant amounts, researchers from Stanford University, Stanford, CA recently reported.

A 17-year population study in Minnesota uncovered suggestions that the rate of decline in testosterone levels may play a role in the rate at which BPH increases and urinary flow decreases, but the associations are far from clear.

Implementation of the "Red Flags Rule" by the Federal Trade Commission, which would require medical practices and other businesses to take specific steps to minimize identity theft and which has been challenged by the AUA, has been delayed until a federal appeals court rules on a lawsuit by the American Bar Association.

Most urologists are concerned about radiation exposure from CT scans, and many have begun to consider more carefully the relative risks and benefits of CT and other imaging techniques.

In this article, we discuss the evolution of mid-urethral sling kits, outline the advantages and disadvantages of three distinct approaches to MUS placement, and provide an overview of our algorithm for procedure selection.

In an era in which we increasingly strive to optimize men's health, an understanding of the complex interaction of medical therapies designed to improve voiding (alpha-blockers and 5-alpha-reductase inhibitors), sexual function (testosterone), and lipid metabolism (statins) will be better described.

A newer selective alpha-1 blocker provided statistically significant reductions in BPH symptom scores compared with placebo and was well tolerated in a study from several European institutions.

With real-time claims adjudication, a patient receives a service in your office and then in real time, while the patient is in the office, she receives an explanation of benefits that details her charges, what the insurance company allows, the amount of the co-pay, and the status of the patient's deductible.

Unlike PSA, the PCA3 assay can identify prostate biopsy outcomes even in men taking a 5-alpha-reductase inhibitor.

Five-alpha-reductase inhibitors may do more than treat BPH and reduce prostate cancer risk; they may ease chronic prostatitis/chronic pelvic pain syndrome symptoms.